The Upcoming PCAC Meeting The FDA notice confirms that the PCAC will convene this summer to evaluate whether to recommend the following seven bulk drug substances for inclusion on the 503A bulks list: July 23, 2026: BPC-157 (free base / acetate) KPV (free base / acetate) Thymosin Beta-4, Fragment (LKKTETQ) (TB-500) (free base / acetate) MOTs-C (free base / acetate) July 24, 2026: Emideltide (DSIP) (free base / acetate) Semax (free base / acetate) Epitalon (free base / acetate) All seven substances are of considerable interest to compounding pharmacies, prescribers, and patients
Who is this lyophilized peptide kit intended for, and who should avoid it
L-ascorbic acid (vitamin C) oxidizes the copper(II) ion in GHK-Cu, neutralizing both actives
PMID: 35507159 Sci Total Environ Silver nanoparticles (AgNPs) and AgNO3 perturb the specification of human hepatocyte-like cells and cardiomyocytes
SHIRLEY, NY 11967 Carton CYANOCOBALAMIN INJECTION, USP 10,000 mcg/10 mL (1,000 mcg/mL) NDC 0517-0032-25 25 x 10 mL MULTIPLE DOSE VIALS FOR INTRAMUSCULAR OR SUBCUTANEOUS USE ONLY Rx Only Each mL contains: Cyanocobalamin 1000 mcg, Benzyl Alcohol 1.5%, Sodium Chloride 0.9%, Water for Injection q.s
